Sangamo Acquisition Of Edwards’ R&D Program Will Enhance Partnering Opportunities
This article was originally published in The Pink Sheet Daily
Executive Summary
Sangamo will acquire Edwards’ angiogenesis program based on zinc finger protein activation of the VEGF gene.